Collectively, our findings indicate that montelukast confers vascular protection in a CaCl2-induced rat model of AAA through complementary mechanisms, including suppression of MMP activity, reduction of MPO-derived oxidative stress, and restoration of antioxidant capacity. Here, MPO is linked to triple-A syndrome.